Man Group PLC X Biotech Inc. Transaction History

Man Group PLC

$37.6 Billion
Q2 2024

A detailed history of Man Group PLC transactions in X Biotech Inc. stock. As of the latest transaction made, Man Group PLC holds 10,611 shares of XBIT stock, worth $75,338. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,611

Holding current value

$75,338

% of portfolio

0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.54 - $9.89 $48,173 - $104,942	10,611 New	10,611 $54,000
Q4 2023 Feb 14, 2024	BUY	$3.56 - $4.65 $15,518 - $20,269	4,359 Added 8.07%	58,355 $233,000
Q3 2023 Nov 14, 2023	BUY	$4.02 - $5.81 $10,870 - $15,710	2,704 Added 5.27%	53,996 $222,000
Q2 2023 Aug 14, 2023	BUY	$3.06 - $6.38 $3,335 - $6,954	1,090 Added 2.17%	51,292 $304,000
Q1 2023 May 15, 2023	BUY	$3.22 - $4.72 $3,828 - $5,612	1,189 Added 2.43%	50,202 $173,000
Q4 2022 Feb 14, 2023	BUY	$3.03 - $3.79 $96,090 - $120,192	31,713 Added 183.31%	49,013 $172,000
Q3 2022 Nov 14, 2022	BUY	$3.58 - $5.88 $61,934 - $101,724	17,300 New	17,300 $63,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.88M

Call Options Held

5.8K

Put Options Held

4.6K

Black Rock Inc. New York, NY

1.13M
Shares

$8.05 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.06M
Shares

$7.54 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

452K
Shares

$3.21 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

362K
Shares

$2.57 Million
0.0% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

254K
Shares

$1.8 Million
0.0% of portfolio

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $216M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account